Tissue microarray analysis of C-MYC oncogene copy number changes in larynx carcinoma

被引:7
|
作者
Koynova, DK
Tsenova, VS
Toncheva, DI
机构
[1] Med Univ Sofia, Dept Med Genet, BG-1431 Sofia, Bulgaria
[2] Univ Hosp Queen Joanna, Dept Pathol, Sofia, Bulgaria
关键词
C-MYC; larynx cancer; fluorescent in situ hybridization; tissue microchips;
D O I
10.1159/000084995
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Purpose of the Study: Copy number changes and structural rearrangements of 8q in tumors from the head and neck region have been reported by numerous studies. To give better insights into the role of 8q abnormalities in larynx carcinoma, C-MYC copy number changes were studied in a large number of tumor materials. Procedures: Fluorescent in situ hybridization with DNA locus-specific probe for C-MYC gene was applied on tissue microarrays presented by 863 larynx tumors. Results: 32.02% had increased copy number of C-MYC. Of these, 6.16% had amplification and 25.86% had C-MYC gains. The analysis revealed a significant difference in the frequency of gains in primary and advanced tumors. Furthermore, we observed an association of gains with advanced clinical stage (I-III to IV). No association was found between the frequency of oncogene amplification and the tumor phenotype. Conclusions: These results suggest that the C-MYC gains are significant for the larynx tumor progression. Copyright (C) 2005 S. Karger AG, Basel.
引用
收藏
页码:92 / 95
页数:4
相关论文
共 50 条
  • [31] C-MYC ONCOGENE EXPRESSION - A MARKER FOR FEMALES AT RISK OF BREAST-CARCINOMA
    HEHIR, DJ
    MCGREAL, G
    KIRWAN, WO
    KEALY, W
    BRADY, MP
    JOURNAL OF SURGICAL ONCOLOGY, 1993, 54 (04) : 207 - 210
  • [32] Tissue microarray analysis of EGFR and erbB2 copy number changes in ovarian tumors
    Dimova, I
    Zaharieva, B
    Raitcheva, S
    Dimitrov, R
    Doganov, N
    Toncheva, D
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2006, 16 (01) : 145 - 151
  • [33] The proto-oncogene c-myc and apoptosis
    Hoffman, B
    Liebermann, DA
    ONCOGENE, 1998, 17 (25) : 3351 - 3357
  • [34] IMMUNOGLOBULIN GENES AND THE C-MYC ONCOGENE IN PLASMACYTOMAGENESIS
    POTTER, M
    MOUNT SINAI JOURNAL OF MEDICINE, 1986, 53 (03): : 216 - 222
  • [35] AN IMMUNOHISTOCHEMICAL STUDY OF C-MYC ONCOGENE EXPRESSION IN RENAL-CELL CARCINOMA
    LANIGAN, D
    MCLEAN, P
    MURPHY, D
    DONOVAN, M
    CURRAN, B
    LEADER, M
    JOURNAL OF PATHOLOGY, 1991, 163 (02): : A156 - A156
  • [36] Role of the oncogene c-Myc in melanoma survival
    Nikiforov, MA
    Soengas, M
    Tkachuk, M
    Mannava, S
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2005, 124 (04) : A148 - A148
  • [37] Oncogene addiction to c-MYC in myeloma cells
    Holien, Toril
    Sundan, Anders
    ONCOTARGET, 2012, 3 (08) : 739 - 740
  • [38] MULTIFACTORIAL REGULATION OF THE HUMAN C-MYC ONCOGENE
    ZAJAC-KAYE, M
    AVIGAN, M
    TAKIMOTO, M
    PITTALUGA, S
    QUINN, J
    GELMANN, E
    LEVENS, D
    CURRENT TOPICS IN MICROBIOLOGY AND IMMUNOLOGY, 1988, 141 : 247 - 252
  • [39] The proto-oncogene c-myc and apoptosis
    Barbara Hoffman
    Dan A Liebermann
    Oncogene, 1998, 17 : 3351 - 3357
  • [40] An immunological approach to functional analysis of the c-MYC proto-oncogene
    Chenette, E
    Wang, DN
    FASEB JOURNAL, 1999, 13 (07): : A1481 - A1481